Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (KCT0011519) titled 'Establishing the Concept of Inflammatory Dry Eye Through Tear Proteomics and Clinical Indicators and Optimizing Treatment with Cyclosporin A 0.05% Eyedrops' on Jan. 22.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Not Applicable
Primary Sponsor: Gyeongsang National University Hospital
Condition:
Diseases of the eye and adnexa
Intervention:
Drug : Instill one drop of Cyclosporine Ophthalmic Solution 0.05% into each eye twice daily at approximately 12-hour intervals for 8 weeks.
Recruitment Status: Not Recruiti...